Abstract: Malaria is one of the most serious widespread diseases encountered by human and it is the second leading cause of death from infectious diseases next to HIV/AIDS in
II.
Materials and Methods
Plant material preparation
Fresh leaf of B. Polystachya (100 g) was collected during the month of November, 2013 from University of Gondar maraki campus, 750km northwest to Addis Ababa, Ethiopia. The plant was identified by a taxonomist, and a voucher specimen (001) was deposited in the National Herbarium, College of Natural Sciences, Addis Ababa University.
Leaves of B. polystachyawas thoroughly washed with distilled water to remove dirt and dried under shade and crushed into coarse powder. The powdered plant material was macerated in 80% of methanol for 72 h with occasional stirring. The filtrate was separated from the mark using Whatman Number 1 filter paper and the mark was re-macerated three times. The filtrates were combined and dried in an oven at the temperature not exceeding 40 o C. The dry extract was blue black dried powder and solid at room temperature. It was weighed by analytical balance and the yield was 34.85%. It was then transferred into vials and kept in desiccators until use [27, 28] .
For this study, 80% of methanol, instead of water, was used to get greater percent of extract yield based on previous studies conducted [21] . Importantly, methanol serves as a less medium for the occurrence of the micro-organisms, it is more efficient in cell wall and seed degradation as well as it has low or no enzyme activity as compared to water [29] . Additionally, alcoholic or hydro alcoholic extract of plant materials contain a wide variety of polar (and moderately polar) compounds [30, 31] . DOI: 10.9790/3008-1105012735 www.iosrjournals.org 29 | Page
Preliminary phytochemical screening
Standard tests were employing to detect the major secondary metabolites such as phenolic compounds, saponins, flavonoids, Tannins, Sterols, Resins, Anthraquinones, alkaloids, Cardiac glycosides and Terpinoids [29, 32] . Look Annex 1.
Experimental animals
A total of 30 adult albino mice of both sex were used for the whole experiment and they were obtained from colonies in the animal unit of the University of Gondar, College of Medicine and Health Sciences, Department of Pharmacology. They were 6-8 weeks of age and had weights ranging from 20 to 36 g. They were housed in plastic cages with standard wood chip bedding and had access to food and water ad libitum. Light was in its natural cycle (for a 12 h on and 12 h off). Care and handling of the mice was performed according to the guidelines given by OECDand ILAR [33] [34] [35] .
Acute toxicity test
The crude extract was evaluated for its toxicity in P. berghei non-infected young female, nulliparas and non pregnant, Swiss albino mice aged six to eight weeks and weighing 28-34g. Oral Acute toxicity study was conducted based on the limit test as per the internationally accepted protocol drawn by OECD [36] . The mice were kept for week prior to dosing to acclimatize and then fasted for 3h food but with normal supply of water. The fasted body weight (BW) of each animal was determined and the doses were calculated according to the body weight. The test substance was administered at 2000mg/kg by oral route. After the administration, food was withheld for a further 2 hours. Animals were observed continuously during the first 30 min after dosing and observed periodically (with special attention given during the first 4 hours) for the next 24 hours and then daily thereafter for 14 days. All observations were systematically recorded with individual records being maintained for each animal within the 24 hours test period. Clinical signs observed included increased motor activity, anaesthesia, tremors, rolling, colonic convulsions, tonic extension, lacrimation, pilo-erection, salivation, muscle spasm, writhing, depression, stimulation, blanching, and cyanosis. Following the results from the first mouse, other two mice were recruited and fasted for 3 h and administered a single dose of 2000 mg/kg and observed in the same manner. These observations continued for further 14 days for any signs of overt toxicity, and individual weights of animals were recorded before the administration of drug on 1st day of the study and thereafter on the 7th and 14th day of the experiment [36] .
Parasite
P. berghei ANKA(Antwerp/Kasapa) strain (Chloroquine sensitive) were obtain from EHNRI and the parasites were subsequently maintained in the laboratory by serial blood passage from infected mice to noninfected ones on weekly basis.
Plasmodium berghei infection
CQ-sensitive strain of the rodent parasite P. berghei was kept alive by continuous intra peritoneal (IP) passage in mice on a weekly base. Percent parasitaemia of the donor mouse was first determined (about 20 to 30% Para) and blood was collected by gentle cardiac puncture from the donor mouse using syringe after it has been sacrified using Ketamin 0.2ml. Then, 1ml of blood was diluted with 4ml of physiological saline (0.9%) which contain 3.8% Tri sodium Citrate (TC) to maintain isotonic condition, such that 1ml of the dilution contains 5×10 6 of infected erythrocytes. Therefore, each mouse was infected on day zero (D0) intraperitoneally with 0.2ml dilution of infected blood (standard inoculums) containing approximately 1x10 6 P. Berghei parasitized red blood cells (10 million parasites in 0.2) [37] .
Antimalarial activity (4-day suppressive) test

Grouping and dosing of animals
The animals were randomly divided into 5 groups, each comprising five animals. Group I served as negative control and was administered 0.2ml of distilled water (dh 2 o). Group II-IV were administered three dose levels of the extract: Low-100mg/kg (B100), Moderate-200mg/kg (B200) and High-300mg/kg (B400). Group V served as positive control and treated daily with 10mg/kg of CQ. All the extract and the drug were administered orally for four consecutive days (starting from day 0 in a 24hr schedule) using oral gavage to insure safe ingestion. The various doses for the extract were selected based on previous reports [12, 21, 38] and then administered based on both their body weight and group.
Parasitological study
On day 4 (96hours) post infection, drop of blood was collected from the mice by venesection of the tail and transferee onto the edge of a microscopic slide and drawn evenly across a second slide to make a thin and 
Determination of body weight
The body weights of the mice were measured to observe whether the test extract of B. polystachya leaves extract prevent body weight loss that is commonly reduced with increasing parasitaemia in infected mice. The weights were taken on D0 (after infection is initiated) and D4 (Day four) [13] .
Determination of mean survival time
Survival time was recorded to observe the effect of the extract for improvement in survival days. The animals were fed ad libitum and was observed for about 28 days. Any death that occurred during this period was noted to determine the mean survival time (MST) [11] . 
Statistical analysis
Data obtained from the study are presented as mean ± standard error of mean. Data Analysis was performed using Statistical Package for Social Science (SPSS), version 20. Comparison of levels of parasitaemia, body weight and survival times of the P. berghei infected mice in non infected mice values between the control and extract treated groups were determined by one-way ANOVA followed by post hoc (Tukey method), while multiple comparison and paired t-test were employed to test significance for the difference between initial and final results within the same group. The significance was set at p<0.05.
III. Results
Phytochemical study
The result of preliminary phytochemical screening of the hydro alcohol leaf extract of B. polystachya is found in Table 1 and it revealed that the extract contains phenolic compounds, saponins, flavonoids, tannins, sterols, resins, anthraquinones while alkaloids, cardiac glycosides and terpinoids compounds were absent. The test was done by using specific chemicals based on Annex 1. did not cause mortality. The body weights of all mice had shown normal increments instead, which was found to be statistically insignificant (P> 0.05).
Antimalarial activity (suppressive) tests
Antimalarial suppressive test results of hydro alcohol extract of the leaves of B.polystachya against P. berghei in Swiss albino mice is shown inTable2. When compared with the respective negative control group (Group I), the oral doses of the extract B100, B200 and B400 induced a statistically significant (P<0.05) suppression of parasitaemia (40.00 %, 54.17 % and 66.67%respectively) on day four of post infection. Among the extract tested, the highest level of inhibition (66.67%,P< 0.001) was observed in B400, while the lowest suppression (40%,P<0.01) was obtained in B100. These groups (B100, B200 and B400) were observed with significant (P<0.05) lower percent parasitaemia levels of 14.4±2.71, 11.0 ± 1.00 and 8.00±1.22 % respectively when compared with Group I (24.0±1.87 %). The difference in parasitaemia reduction among extract treated groups, nevertheless, was statistically insignificant (P>0.05). In the same assay, on day 4, Chloroquine had a chemo suppression of 100% at the dose level of 10 mg/kg/day and showed significant suppression (P<0.05) when compared with extract treated groups. Percent parasitaemia level was directly proportional with concentration gradient of an extract. Key: Data are expressed as means ± SEM for five mice per a group; A =the mean value is significant when compared with vehicle treated group; B = mean value is significant when compared with Chloroquine treated group.1=the mean value is significant (P < 0.05); 2= the mean value is significant (P < 0.01); 3= the mean value is significant (P < 0.001).
Determination of body weight
Between D0 (day zero) and D4 (day four), there was significant decrease in body weight inB200 (P<0.05) and B400 (P<0.01), and insignificant decrease (P>0.05) for B100, Group I and Group V. In addition, analyses of variance conducted between the extract treated groups in comparison with the respective control have showed insignificant deviation. Extract of B.polystachya leaves did not prevent a loss of body weight in infected mice with increasing parasitemia. Key: Data are expressed as means ± SEM for five mice per group; Weight D0: Weight pretreatment on day zero; Weight D4: weight post-treatment on fifth day * = statistically significant (P<0.05) between D0 and D4 within group.
Determination of mean survival time
Majority of the treated groups lived longer than the corresponding negative control. B100, B200 and B400 had mean survival time of 7.4 ±0.75, 10.0 ±0.84 and10.2 ±0.73 respectively, while Group I (the negative control) lived 6.8 ±0.37, as shown in Table 4 . Although all the extract treated groups lived longer than the negative control group, significant difference was observed with B200 and B400(P<0. 05 Key: Data are expressed as means ± SEM for five mice per group: A= the mean value is significant (P<0.05) when compared with Group I, B=the mean value is significant (P<0.05) when compared with Group V, C = the mean value is significant (P<0.05) when compared with Group III. 1=the mean value is significant (P < 0.05); 2= the mean value is significant (P < 0.01); 3= the mean value is significant (P < 0.001).
IV. Discussion
Typical acute toxicity (such as changes in general behaviours, variations in body weight and mortality) with the test extract was not observed during the given period of test [10, 41] . Since the maximum dose level recommended by OECD is 2000 mg/kg body weight, further dosing to estimate the median Lethal Dose (LD 50 ) of the plant was not performed. Actually, at the end of 14 days no death and no adverse effects of extract was recorded at 2000mg/kg, which was about5 times the maximum effective dose tested (400 mg/kg). Based on the result, it can be stated that B.polystachy's LD50value is greater than 2000mg/kg and this plant can be classified under category 5 in accordance with Globally Harmonised System of Classification and Labelling of chemicals [10, 42] . The rodent malaria model is the prominent step to screen most of the in vivo antimalarial activities of extracts and metabolites, even though it is not exactly similar to that of the human plasmodium infection [10, 44] . Importantly, pharmacological agents such as Chloroquine, Halofantrine, Mefloquine and more recently artemisinin derivatives have been studied using this model. More importantly, it is also cost effective to conduct preliminary pharmacological screening studies of crude extract in rodent model than primate model [13] . The in vivo model was employed for this study since it takes into account the possible prodrug effect and the possible involvement of the immune system in eradication of infection as compared to an in-vitro study [44] .In antimalarial drug discovery process, there are number of established in-vivo murine plasmodium models, although plasmodium berghei was used in this study since it is an appropriate parasite that is most commonly used. Likewise, as this parasite is sensitive to and significantly suppressed by chloroquine, this drug was employed as a standard [44] . Interestingly, this 100% suppression effect of chloroquine was observed in this study.
The four-day suppressive test is a standard test commonly used for early antimalarial screening and the determination of percent inhibition of parasitaemia is the most reliable parameter [45] .In this study, the suppression activity of all doses of the extract was statistically significant in spite of its inconsistency with increasing dose on day4. The extract of B.polystachya had shown highest level of parasitemia suppression (66.67%, P<0.001) in the higher dose with relatively longest survival time compared to the negative control group and the remaining two extract doses. Subsequently, it can be suggested that 400mg/kg of extract might be the optimal effective therapeutic dose. Interestingly, the present result is in line with hydro methanolic leaf extract of Calpurnia aurea (Fabaceae) [28] . The lower efficacy of the extracts (at all doses used) than Chloroquine may be in part due to unpurified/crude nature, non selectivity, pharmacokinetics and pharmacodynamic parameters of the crude extract [46] . Similarly, the vitro antibacterial properties of the methanol extract of B.polystachya was not as effective as the standard drugs (Ampicillin and Gentamicin), although it showed some activity against bacterial strains used [21] .
Although mechanism of action of these secondary metabolites was not evaluated in the present study, its antimalarial activity might be attributed to the presence of phytochemical constituents (such as saponins and flavonoids)in many plants that produce a definite antiplasmodial activity which finally modify physiological action on the human body relate to malarial infection [47] . Species from the genus Buddleja have been reported to exhibit moderate antiplasmodic activity for H-hypoxanthin up take in cultured plasmodium falciparum.The active antiplasmodial constituents of Buddleja polystachyaleaves may be novel or similar to those active constituents of Buddleja globsa [38] .
It is a good step that the result had clearly showed that this extract contains saponins, polyphenols, tannins& flavonoids and these chemical compounds may be acting in synergy with one another to exert the observed antimalarial activity of the extract [12] . Like other antimalarial agents, the mechanism of action of this plant might be due to antioxidant properity, immunomodulatory effects, intercalation with the parasite DNA, DOI: 10.9790/3008-1105012735 www.iosrjournals.org 33 | Page protein binding, enzyme inhibiting properties, and anti inflammatory activity [11, 46, 48, 49] . Moreover, the confirmed in vitro antibacterial activity of the species within the genus Buddleja support the present study in which the genus is rich in active antibiotic phytochemical ingredients that could probably suppress parasitaemia of the malaria parasites. Consequently, the extract could have elicited its action through any of the above mentioned mechanism or by some other means yet to be determined. Regarding the effect on body weight, it has been observed that the extract's preventive effect on loss of weight decreased with increasing dose. This might indicate that the plant could have an increased anorexic effect with escalating dose. This appetite suppressing activity of the extract might be ascribed to saponins, flavonoids, and phenolic compounds [43] . Importantly, this result is consistent with previous reports on hydro methanolic extract of Calpurnia aurea (Fabaceae), Dodonaea angustifolia and other plants [11, 28, 50] . The result of the present study on body weight, however, was not similar with that of Chloroform and Butanol fractions of D. Angustifolia [13] .
The extract prolonged the mean survival time of the mice indicating that it suppresses P. berghei as well as reduces the overall pathologic effect of the parasite on these mice [12] . This study is similar with other study made on the effect of hydro alcoholic extraction of D. Angustifolia on mean survival time [11] . Similarly, like other in vivo antimalarial studies, the longest mean survival time of the mice was strongly associated with the maximum parasitemia inhibition [51] .
Importantly, a compound is considered as an active antimalarial agent when it reduces parasitaemia level by ≥ 30% which gives a sufficient ground to claim that the result of the parasite suppression of the present study showed antimalarial activity [37] .More importantly, an in vivo anti-plasmodial activity can be classified as moderate, good and very good if an extract displayed percent parasitemia suppression equal to or greater than 50% at a dose of 500 mg, 250 mg and 100 mg/kg per day respectively [52] . Based on this classification, the parasitemia chemosuppression of this extract was fairly below 50% at B100, while the optimum doses (B200 and B400) has provided a drastic parasite suppression (>50%). Subsequently, it can be concluded that the hydromethanolic leaf extract of B.Polystachya exhibited a good anti-plasmodial activity.
V. Conclusion
This study collectively indicates that the hydro alcoholic extract of B.polystachya plant is not toxic and does not cause major acute toxic symptoms on acute toxicity test bases. The extract also possesses promising anti-plasmodial activity, which can be more evaluated for its profound activities by further researches. It contains phenolic compounds, saponins, flavonoids, tannins, sterols, resins and anthraquinones, while alkaloids, cardiac glycosides and terpinoids compounds are absent.
VI.
Limitations of the study 1 . The use of only polar extract instead of non polar extract. This means some of the compounds which may have a therapeutic effect in an extract may be absent in the test samples. 2. Unavailability of culture conditions or vitro assay which may reduce the use of animals and also gives more representative (confirmatory) outcomes in the antiplasmodial assays than study in vivo alone.
